Fooling others — and himself — into believing his MS symptoms weren't a big deal wasn't a good approach, writes columnist Be.

Discover how MS patients overcome challenges, raise awareness, and lead fulfilling careers in healthcare. Across the UAE, ...

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the Phase III MUSETTE trial comparing a high dose of OCREVUS® (ocrelizumab) intravenous (IV) infusion to the currently approved OCREVUS IV 600 ...

Mary-Frances O’Connor: The chronic stress that we find co-occurs with prolonged grief is associated with longer term ...